Table 3.
All Participants (n=15 376) | CVD‐Free Participants (n=13 278) | Prevalent CVD (n=2098) | ||||
---|---|---|---|---|---|---|
HR (95%CI) | P Value | HR (95%CI) | P Value | HR (95%CI) | P (95%CI) | |
DTNPV1 | 2.37 (1.44 to 3.91) | 0.001 | 3.51 (1.72 to 7.13) | 0.001 | 2.05 (1.11 to 3.70) | 0.022 |
Female | 0.56 (0.41 to 0.77) | <0.0001 | 0.45 (0.32 to 0.68) | <0.0001 | 0.68 (0.41 to 1.11) | 0.122 |
Age, y | 1.006 (1.003 to 1.008) | <0.0001 | 1.07 (1.04 to 1.10) | <0.0001 | 1.04 (1.00 to 1.08) | 0.057 |
CHD | 0.30 (0.04 to 2.19) | 0.234 | — | 0.82 (0.19 to 3.54) | 0.417 | |
MI | 15.81 (2.17 to 114.96 | 0.006 | — | 6.22 (1.52 to 25.49) | 0.011 | |
HF | 0.80 (0.53 to 1.23) | 0.318 | — | 1.01 (0.63 to 1.60) | 0.983 | |
Stroke | 1.80 (1.15 to 2.83) | 0.010 | — | 2.22 (1.40 to 3.52) | 0.001 | |
BMI, kg/m2 | 1.00 (0.97 to 1.02) | 0.848 | 0.99 (0.96 to 1.02) | 0.647 | 1.01 (0.97 to 1.05) | 0.568 |
Total cholesterol, mmol/L | 1.21 (1.09 to 1.34) | <0.0001 | 1.18 (1.04 to 1.35) | 0.009 | 1.27 (1.08 to 1.50) | 0.003 |
HDL, mmol/L | 0.57 (0.39 to 0.84 | 0.005 | 0.56 (0.36 to 0.89) | 0.014 | 0.68 (0.35 to 1.31) | 0.258 |
Triglycerides, mmol/L | 0.98 (0.88 to 1.08) | 0.679 | 0.97 (0.85 to 1.11) | 0.663 | 0.96 (0.80 to 1.14) | 0.637 |
Leisure activity index | 0.87 (0.69 to 1.08) | 0.209 | 0.75 (0.57 to 0.99) | 0.046 | — | |
Diabetes mellitus | 2.24 (1.68 to 3.00) | <0.0001 | 2.82 (1.98 to 4.00) | <0.0001 | 1.56 (1.00 to 2.43) | 0.048 |
Current smoking | 2.00 (1.54 to 2.58) | <0.0001 | 2.13 (1.55 to 2.93) | <0.0001 | 1.68 (1.12 to 2.50) | 0.011 |
Systolic blood pressure, mmHg | 1.01 (1.01 to 1.02) | <0.0001 | 1.02 (1.01 to 1.02) | <0.0001 | 1.01 (1.01 to 1.02) | 0.002 |
BP lowering drugs | 1.35 (1.03 to 1.77) | 0.029 | 1.74 (1.24 to 2.44) | 0.001 | 0.95 (0.62 to 1.44) | 0.794 |
QT‐prolonging drugs | 1.05 (0.72 to 1.53) | 0.787 | 1.01 (0.61 to 1.69) | 0.958 | 1.03 (0.62 to 1.73) | 0.903 |
Beta‐blockers | 0.96 (0.67 to 1.53) | 0.824 | 0.55 (0.30 to 1.01) | 0.054 | 1.23 (0.78 to 1.94) | 0.367 |
Cornell productsex, mm×ms | 1.00 (1.00 to 1.00) | 0.519 | 1.00 (1.00 to 1.00) | 0.361 | — | |
QRS duration, ms | 1.00 (0.99 to 1.01) | 0.411 | 0.98 (0.96 to 1.00) | 0.098 | 1.02 (1.00 to 1.03) | 0.004 |
Heart rate, bpm | 1.01 (0.99 to 1.02) | 0.367 | 1.00 (0.99 to 1.02) | 0.621 | 1.02 (1.00 to 1.04) | 0.027 |
QTc, ms | 1.008 (1.003 to 1.014) | 0.004 | 1.009 (1.001 to 1.017) | 0.022 | 1.00 (0.99 to 1.01) | 0.531 |
P duration, ms | 1.00 (0.99 to 1.01) | 0.462 | 0.99 (0.98 to 1.00) | 0.131 | 1.01 (1.00 to 1.03) | 0.046 |
P axis, deg | 1.00 (0.99 to 1.00) | 0.331 | 0.99 (0.99 to 1.00) | 0.129 | — | |
QRS‐T angle, deg | 1.005 (1.002 to 1.009) | 0.001 | 1.00 (1.00 to 1.01) | 0.062 | — | |
Itraatrial block third degree | 1.20 (0.43 to 3.37) | 0.727 | 1.38 (0.33 to 5.78) | 0.660 | — |
CHD indicates coronary heart disease; DTNPV1, deep terminal negativity of P wave in V1; HF, heart failure; MI, myocardial infarction.